Videos

GIls
Roex
FWO
UAntwerpen

A slick CAR in the race against leukaemia

Cancer is a sneaky disease. For instance, cancer cells sometimes manage to disguise themselves, outrunning our immune system. Gils Roex (UAntwerpen - FWO) explains how equipping our white blood cells with a cleverly designed CAR could well help win the race against blood cancer. Want to know more? Fasten your seatbelts & watch the video 🏎
Kim
De Veirman
FWO
VUB

Camel blood attacks dormant cancer cells

Why do cancer patients relapse despite receiving treatment? This is often due to dormant cancer cells. These cells lie dormant in the body and manage to escape treatment, for example, chemotherapy. Can substances from camel and llama blood provide a breakthrough?
Heleen
Hanssens
FWO
VUB

How we teach your body to unmask cancer

Did you know that cancer cells are not so different from our healthy cells? This makes it difficult for T-cells, important immune cells in our body, to recognise and fight cancer cells. Cancer researcher Heleen Hanssens (VUB-FWO) wants to give T-cells a helping hand by equipping them with more sensitive receptors, or antennae, that are pre-programmed to unmask cancer cells. In the lab, she is looking for the perfect form for these CAR antennae, so that they become more stable and better at detecting cancer cells. 
Leen
Van den Steen
FWO
UAntwerpen

Swallowing rehabilitation in head and neck cancer patients

Radiation can save the lives of people with head and neck cancer. Unfortunately, many patients develop swallowing disorders as a result of the treatment, which makes it impossible for them to eat solid food. Leen Van den Steen (UAntwerpen - UZA) wants to help them. How? With tongue strength training.
Liselore
Loverix
FWO
KU Leuven

Let's no longer treat every ovarian cancer patient the same way

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.
Tim
Bomberna
FWO
UGent

Liver cancer: how do we get the medicines to the tumor?

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.
Jolien
De Munck
VUB

Viruses as allies in the fight against cancer

With the current corona pandemic, viruses are seen as more dangerous than ever. But did you know that some viruses can help us fight cancer? Jolien De Munck is studying the potential of these so-called 'oncolytic viruses'.
Michelle
Melis
FWO
KU Leuven

Chemo also affects the brain

Chemotherapy affects the brains of patients. It can lead to cognitive complaints, stress, and fatigue. Michelle Melis achieves promising results with mindfulness in patients with breast cancer. 
Sebastiaan
Vanuytven
FWO
KU Leuven

Analysis of tumours, cell by cell

What is the link between a smoothie and the analysis of cancer tumours? Well, Sebastiaan Vanuytven explains it smooth(l)y in this video
Mónica
Vara Perez
FWO
KU Leuven
VIB

Understanding the self-cannibalism instincts of melanoma

Melanoma is a very common and lethal type of skin cancer. Melanoma cells have a strange, yet effective defence mechanism called autophagy: they can manage to survive by eating parts of themselves. Monica Vara Perez tries to figure out this self-cannibalism mechanism in order to help defeat melanoma.
Joeri
Lambrecht
VUB

A quick method to detect liver fibrosis through the blood

Joeri Lambrecht (VUB - Vrije Universiteit Brussel) developed a simple blood test that allows for a faster, safer and cheaper detection of liver fibrosis.
Matteo
Rossi
FWO
KU Leuven
VIB

Finding the weak spot of breast cancer cells

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.